Cascara Sagrada 450 mg By FDC Overview & Drug Interactions

Check For Interactions With Cascara Sagrada 450 mg

Supplement: Cascara Sagrada 450 mg by FDC

Cascara Sagrada 450 mg Label Images

This product contains

Below is a list of the 'active' ingredients listed on the supplement label for this product.

For a list of 'other ingredients', such as fillers, please see the 'Label Information' section on this page.

Drugs that interact with Cascara Sagrada 450 mg by FDC

Below is a list of drug interactions for each ingredient in this supplement product. Please note that a supplement product may contain more than one ingredient that has interactions.

Label Information

Supplement Facts:

Daily Value (DV) Target Group(s): Adults and children 4 or more years of age
Minimum serving Sizes:
1 Capsule(s)
Maximum serving Sizes:
1 Capsule(s)
Servings per container 90
UPC/BARCODE FDC7053

Ingredient Amount per Serving Group % DV, Adults & children 4+ years
Cascara Sagrada
450 mg
Cascara Sagrada --

Other Ingredients:
Gelatin
Magnesium Stearate
Silicon Dioxide


Label Statments:


Suggested/Recommended/Usage/Directions
- Directions: Adults-take one (1) capsule daily, preferably after meals, as a dietary supplement.
Precautions
- Warnings: If you are pregnant, nursing or taking any medications, consult your doctor before use.
- Discontinue use and consult your doctor if any adverse reactions occur..
FDA Statement of Identity
- herbal supplement
General Statements
- SKU FDC7053

Brand Information

See all products by this brand

Not Present
Name FDC Vitamins LLC

Return to the main supplement interaction checker page

Parts of this content are provided by the Therapeutic Research Center, LLC and the Dietary Supplement Label Database.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Drug descriptions are provided by MedlinePlus.